Head to Head Survey: Precision Optics (NASDAQ:POCI) vs. IceCure Medical (NASDAQ:ICCM)

Precision Optics (NASDAQ:POCI) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, institutional ownership and valuation.

Analyst Ratings

This is a summary of current ratings and price targets for Precision Optics and IceCure Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	1	0	0	0	1.00
IceCure Medical	2	0	3	0	2.20

IceCure Medical has a consensus target price of $52.50, suggesting a potential upside of 3,150.77%. Given IceCure Medical’s stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Precision Optics.

Risk and Volatility

Precision Optics has a beta of 0.32, suggesting that its share price is 68% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500.

Profitability

This table compares Precision Optics and IceCure Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precision Optics	-11.51%	-23.92%	-13.05%
IceCure Medical	-427.67%	-174.26%	-112.58%

Earnings & Valuation

This table compares Precision Optics and IceCure Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$31.53 million	1.44	-$5.78 million	($0.46)	-9.02
IceCure Medical	$3.38 million	1.64	-$15.06 million	($8.52)	-0.19

Precision Optics has higher revenue and earnings than IceCure Medical. Precision Optics is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 14.4% of Precision Optics shares are held by company insiders. Comparatively, 2.4% of IceCure Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Precision Optics beats IceCure Medical on 8 of the 14 factors compared between the two stocks.

About Precision Optics

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.